Pembrolizumab plus docetaxel for the treatment of recurrent metastatic head and neck cancer: A prospective phase I/II study

被引：1
|
作者：
Fuereder, T. [1 ]
Minichsdorfer, C. [1 ]
Mittlboeck, M. [2 ]
Wagner, C. [1 ]
Oberndorfer, F. [3 ]
Mullauer, L. [3 ]
Aretin, M-B. [4 ]
Czerny, C. [5 ]
Schwarz-Nemec, U. [5 ]
机构：
[1] Med Univ Vienna, Vienna Gen Hosp, Internal Med I, Vienna, Austria
[2] Med Univ Vienna, Vienna Gen Hosp, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria
[3] Med Univ Vienna, Vienna Gen Hosp, Pathol, Vienna, Austria
[4] Vienna Gen Hosp, Pharm, Vienna, Austria
[5] Med Univ Vienna, Vienna Gen Hosp, Biomed Imaging & Image Guided Therapy, Vienna, Austria
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1036
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
921P
引用
收藏
页码：S665 / S665
页数：1
相关论文
共 50 条
  • [21] A phase II trial of docetaxel plus cisplatin in recurrent and/or metastatic non-squamous cell carcinoma of head and neck
    Imamura, Y.
    Kiyota, N.
    Tanaka, K.
    Hayashi, H.
    Ota, I.
    Nario, K.
    Hirano, S.
    Arai, A.
    Iwae, S.
    Onoe, T.
    Minami, S.
    Shimada, T.
    Yane, K.
    Yamazaki, T.
    Nagatani, Y.
    Toyoda, M.
    Otsuki, N.
    Nibu, K-I.
    Minami, H.
    ANNALS OF ONCOLOGY, 2018, 29
  • [22] A phase II study of docetaxel in patients with head and neck cancer
    Inuyama, Y
    Taguchi, T
    ANNALS OF ONCOLOGY, 1998, 9 : 74 - 74
  • [23] Docetaxel (DTX) plus cisplatin (CDDP) in locally advanced or metastatic head and neck cancer (HN). A phase II study.
    Caponigro, F
    Avallone, A
    Rivellini, F
    Sguotti, C
    Manzione, L
    De Lucia, L
    Biglietto, M
    Massa, E
    Comella, P
    Mantovani, G
    Comella, G
    CLINICAL CANCER RESEARCH, 1999, 5 : 3773S - 3773S
  • [24] Phase I study of weekly docetaxel and cisplatin arterial infusion for recurrent head and neck cancer
    Nakamura, Tatsuya
    Fuwa, Nobukazu
    Takayama, Kanako
    Inokuchi, Haruo
    Tomoda, Takuya
    Takada, Akinori
    Makita, Chiyoko
    Shiomi, Miho
    Yokouchi, Jun-ichi
    Watanabe, Kazuo
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (11): : 1634 - 1639
  • [25] A phase 2 study of ipatasertib in combination with pembrolizumab for first line treatment of recurrent or metastatic squamous cell cancer of the head and neck
    Thomas, Jacob S.
    Hsu, Robert
    Villaflor, Victoria
    Riess, Jonathan
    Nieva, Jorge
    Krailo, Mark
    Gutkind, Silvio
    Colevas, Dimitri
    CANCER RESEARCH, 2023, 83 (08)
  • [26] Phase II study of intratumoral MK-1454 plus pembrolizumab compared with pembrolizumab monotherapy as first-line treatment for metastatic or unresectable, recurrent head and neck squamous cell carcinoma
    Harrington, K. J.
    William, W. N., Jr.
    Khilnani, A.
    Algazi, A. P.
    ANNALS OF ONCOLOGY, 2020, 31 : S683 - S683
  • [27] Setanaxib plus pembrolizumab for the treatment of recurrent or metastatic squamous cell carcinoma of the head & neck: Results of a randomized, double-blind phase II trial
    Fayette, J.
    Thomas, G.
    Daste, A.
    Rotarski, M.
    Castelo, B.
    Rullan, A.
    Levine, A.
    Philipson, R. S.
    Harrington, K. J.
    ANNALS OF ONCOLOGY, 2024, 35 : S615 - S616
  • [28] A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer
    Rodriguez, Cristina P.
    Wu, Qian
    Voutsinas, Jenna
    Fromm, Jonathan R.
    Jiang, Xiuyun
    Pillarisetty, Venu G.
    Lee, Sylvia M.
    Santana-Davila, Rafael
    Goulart, Bernardo
    Baik, Christina S.
    Chow, Laura Q. M.
    Eaton, Keith
    Martins, Renato
    CLINICAL CANCER RESEARCH, 2020, 26 (04) : 837 - 845
  • [29] Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck
    Wirth, LJ
    Haddad, RI
    Lindeman, NI
    Zhao, XJ
    Lee, JC
    Joshi, VA
    Norris, CM
    Posner, MR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 6976 - 6981
  • [30] Potential of Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer: Evidence to Date
    McCusker, Michael G.
    Orkoulas-Razis, Dennis
    Mehra, Ranee
    ONCOTARGETS AND THERAPY, 2020, 13 : 3047 - 3059
12345